Davenport & Co’s INmune Bio INMB Stock Holding History

Davenport & Co’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.3K	Hold	10,000	–	–	﹤0.01%	1352
2026 Q1	$11.3K	Hold	10,000	–	–	﹤0.01%	1300
2025 Q4	$15.6K	Hold	10,000	–	–	﹤0.01%	1251
2025 Q3	$20.7K	Hold	10,000	–	–	﹤0.01%	1223
2025 Q2	$23.1K	Buy	+10,000	New	+$73.4K	﹤0.01%	1199

Other funds holding INMB

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Davenport & Co's INMB Position: Q2 2026 in Review

Davenport & Co held its INmune Bio (INMB) position steady in Q2 2026 at 10,000 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

Davenport & Co first reported a position in INMB in Q2 2025 and has held it in 5 quarters since. The position peaked at $23.1K in Q2 2025. 8 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

Davenport & Co held 10,000 shares of INmune Bio worth $16.3K as of Q2 2026.
Davenport & Co left its INmune Bio share count unchanged in Q2 2026.
INmune Bio made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #1352 holding.
Davenport & Co first reported a position in INmune Bio in Q2 2025 and has held it in 5 quarters since.
Davenport & Co's INmune Bio position peaked at $23.1K in Q2 2025.
8 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.